| 标题 |
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Lorcan P McGarvey; Surinder S Birring; Alyn H Morice; Peter V Dicpinigaitis; Ian D Pavord; et al 出版日期:2022-03-05 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)